Clinical Trials Directory

Trials / Completed

CompletedNCT01663376

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia

Effects of Adipose Tissue Derived Stem Cells Implantation in Patients With Critical Limb Ischemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
R-Bio · Industry
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with critical limb ischemia

Conditions

Interventions

TypeNameDescription
PROCEDUREAutologous Adipose Tissue derived MSCs TransplantationIntramuscular injection of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 1x10e8 \~3x10e8 cells

Timeline

Start date
2009-01-01
Primary completion
2010-03-01
Completion
2011-04-01
First posted
2012-08-13
Last updated
2019-06-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01663376. Inclusion in this directory is not an endorsement.